By anchoring production domestically, the partnership positions Celularity (NASDAQ:CELU) toSupplyMuseCell-derived material from an established U.S. manufacturing base rather than relying on external or overseas production capacity, a structure that can matter for supply-chain reliability in cell-therapy manufacturing.
With the IND cleared, Adicet Bio (NASDAQ:ACET) has outlined plans to begin Phase 1 enrollment in the fourth quarter of 2026. As an early-stage, first-in-human study, the initial Phase 1 trial will primarily focus on establishing the safety profile and appropriate dosing of ADI-212, …
1. IRAN: Foreign Ministry Warns Against Complicity With US Sanctions as Diplomatic Signals Mix With Contradictory Claims Over Hormuz
SNDL (NASDAQ:SNDL), one of Canada's largest cannabis and liquor retailers, fell as soft consumerDemandpressured its core retail businesses—even as a fortress balance sheet, activeBuybacksand a bold expansion into U.S. cannabis continue to define the longer-term story. The tension between near-term softness and long-term optionality …
Upwork (NASDAQ:UPWK), the online marketplace connecting businesses with freelancers, jumped as it reported record profitability metrics and surgingDemandfor AI-related work. The move focuses attention on the central tension in Upwork's story: whether artificial intelligence is a threat that automates away freelance work or an …
VirTra (NASDAQ:VTSI), a maker of use-of-force and firearmsTrainingsimulators for law enforcement and military customers, slipped as government funding and procurement timing continued to weigh on its revenue. For investors, the question is whether the next catalyst—a release of budget dollars or a rebound in …
Waterdrop (NYSE:WDH), a Chinese insurance-and-healthcare technology platform, traded roughly flat despite delivering strong revenue growth, consistent profitability andShareholderreturns. Trading at a low valuation with a dividend, the company raises the question of whether it could be ready for its next big move—or whether the …
Rekor Systems (NASDAQ:REKR), a developer of AI-powered roadway-intelligence technology, edged higher as investors weighed improving operating metrics against a stark going-concern warning and a loomingDebtmaturity. The move poses a high-stakes question: is this an opportunity as theBusinessapproaches profitability, or a signal of more risk …
Rail Vision (NASDAQ:RVSN), an Israeli developer of AI-powered obstacle-detection systems for railways, dropped even as its revenue surged from a tiny base and its products began gaining commercial traction. For investors, the weakness poses a familiar early-stage-technology question: can the company find a floor …
Summit Therapeutics (NASDAQ:SMMT), a biotechnology company developing the closely watched cancer immunotherapy ivonescimab, rose as maturing survival data and an approaching regulatory decision reinforced investor optimism. For a company whose value is tightly bound to a single high-profile drug, the question is whether the …